Literature DB >> 26104498

The HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): Clinical characteristics and maternal-fetal outcome in 172 patients.

M L Miranda1, A J Vallejo-Vaz1, L Cerrillo2, M L Marenco3, J Villar1, P Stiefel1.   

Abstract

OBJECTIVES: To analyze the frequency of the different clinical presentations of the disease in women with HELLP syndrome and the most important factors that can predict a different maternal and fetal outcome. STUDY
DESIGN: This is a cross-sectional, consecutive, case-series study, the subjects being all patients with HELLP syndrome admitted to our Hospital within the last decade (1999-2009).
RESULTS: The rate of maternal complications was 43.0% and perinatal mortality 14.1%. The severity of the syndrome, measured by The Mississippi Classification, influenced the rate of maternal complications but not fetal mortality: the rate of maternal complications among women in class 1 HELLP syndrome was 67.6%, compared to 49.3% in class 2 and 24.0% in class 3 HELLP syndrome, p<0.0001. In a 21.8% of women, the onset of the disease was after delivery. We highlight the fact that those cases with an early puerperium onset of the disease were those with a higher number of maternal complications (odds ratio: 2.38; CI: 1.05-5.44).
CONCLUSIONS: These results suggest the possibility of an increased complication rate when the onset of the syndrome appears after delivery and the necessity of having a high grade of suspicion in every case to diagnose the disease, even when the gestation and delivery were normal.
Copyright © 2011 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2011        PMID: 26104498     DOI: 10.1016/j.preghy.2011.01.004

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  2 in total

1.  Description of a strong relationship among total cell-free DNA levels, LDH values, AST values and platelet count in patients with HELLP syndrome.

Authors:  Pablo Stiefel; María L Miranda; Hada Macher; Luis M Beltran-Romero; Rocio Muñoz-Hernandez
Journal:  Hypertens Res       Date:  2017-03-23       Impact factor: 3.872

2.  Recurrent HELLP Syndrome at 22 Weeks of Gestation.

Authors:  Peter Kascak; Milos Paskala; Peter Antal; Radovan Gajdosik
Journal:  Case Rep Obstet Gynecol       Date:  2017-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.